Below, CNBC Select explains the differences between trademarks, copyrights and patents. Read on for more information and to ...
HighlightsThe Company has received a Certificate of Grant from the US Patent and Trademark Office for a key patent for the FAK inhibitor ...
A U.S. appeals court on Tuesday overturned a nearly $42 million jury verdict won by Pfizer's Seagen against Japanese rival ...
On Nov. 28, 2025, the United States Patent and Trademark Office (USPTO) issued new examination guidance clarifying inventorship standards ...
I haven’t given my diatribe on cheap drugs for a while, but what the hell. It’s a huge deal and no one in a position of power ...
Between the 1960s and the 1990s, during the meteoric rise in wealth and living standards of the post-World War II era, ...
Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug ...
On December 7, 1909, Belgian-American chemist Leo Baekeland’s process patent for making Bakelite was granted, two years after ...
Thepatent relates to methods of administering therapeutically effective amounts of isolated allogeneic mesenchymal stem cells (MSCs) to patients with aging-related frailty with inflammaging and also ...
ESTERO, FLORIDA / ACCESS Newswire / December 2, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) (“Aspire” or the ...
Researchers from Johns Hopkins University have developed an oral treatment that could soon be used to destroy cancer cells and even prevent the disease from forming in the human body.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback